Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 41Unknown 19Recruiting 7Not yet recruiting 7Terminated 6Active not recruiting 3Withdrawn 2No longer available 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 437Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 174Colorectal Neoplasms 156Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 130Lymphoma 127Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Brain Neoplasms 101Recurrence 100Head and Neck Neoplasms 100Leukemia, Lymphocytic, Chronic, B-Cell 96Leukemia 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 74Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Interventions

lenvatinib 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Hepatitis B × Clear all
NCT04044651 2020-01-09

Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection

Sun Yat-sen University

Phase 2/3 Withdrawn
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT01831037 2015-01-28

ROLFH

University of Arkansas

Withdrawn
Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis B, Chronic, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡